Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity.
about
Detection of airborne rhinovirus and its relation to outdoor air supply in office environmentsAntihistamines for the common coldIntranasal ipratropium bromide for the common coldIntranasal ipratropium bromide for the common coldAntihistamines for the common coldAntihistamines for the common coldEfficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common coldNeural dysfunction following respiratory viral infection as a cause of chronic cough hypersensitivityMolecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, MalaysiaH3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccinationExpanding the understanding of biases in development of clinical-grade molecular signatures: a case study in acute respiratory viral infectionsRhinovirus infection results in stronger and more persistent genomic dysregulation: Evidence for altered innate immune response in asthmatics at baseline, early in infection, and during convalescenceNasopharyngeal Protein Biomarkers of Acute Respiratory Virus Infection.Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trialTreatment of Acute Cough Due to the Common Cold: Multi-component, Multi-symptom Therapy is Preferable to Single-Component, Single-Symptom Therapy--A Pro/Con Debate.A host-based RT-PCR gene expression signature to identify acute respiratory viral infectionHow Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?An individualized predictor of health and disease using paired reference and target samples.Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial InfarctionGene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humansTemporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection.Bacteria in the nose of young adults during wellness and rhinovirus colds: detection by culture and microarray methods in 100 nasal lavage specimens.A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2.Studies of "natural" remedies for the common cold: pitfalls and pratfallsImmune modulation by aspirin during experimental rhinovirus colds.RHINOVIRUSES AND RESPIRATORY DISEASEProphylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection.Ipratropium bromide treatment of experimental rhinovirus infectionTwo randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.Rhinovirus infection of the normal human airway.Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials.Minimum redundancy maximum relevance feature selection approach for temporal gene expression data.Validity of the common cold questionnaire (CCQ) in asthma exacerbations.Cost-effectiveness of gargling for the prevention of upper respiratory tract infections.Ineffectiveness of echinacea for prevention of experimental rhinovirus colds.Development of a symptom score for clinical studies to identify children with a documented viral upper respiratory tract infection.Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial.ECHO-11 as a respiratory virus: quantitation of infection in man.A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza.Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold.
P2860
Q23922455-7E4A4DFA-0B6C-4699-AAA3-CEEAD6573AFBQ24187606-A9E2F876-E503-41E4-A8F1-397E3A853E03Q24201895-6F33A68F-4BD6-45D3-943E-A0A546A2B2EDQ24235444-82C8128A-6B30-49B8-A857-F671C224893FQ24240755-438D344D-4190-4048-9EAC-69C59C94AD2CQ24247974-8365F8D0-01CC-4B7D-BF47-02D9A10134B7Q24630893-10744980-AD5F-4DCF-8729-BD7A535AECDBQ26860939-DA52F9A5-4E5D-4C70-B434-D43A54E311F6Q28603737-C13ECB18-7FE0-4E09-AC6D-9E0B0018B3AEQ28743596-5B337CE1-0CEB-491A-843C-80ACC34A57B5Q28744065-9F7D259F-03A3-4ECE-BE7C-8A3270D1853EQ30252319-57548A22-7446-48A3-BA5D-0AC5497D4F16Q30253085-C41653CA-8EC2-4C53-B86D-EDB474609422Q30278568-DCD4B7A8-688E-4754-8CC1-41C39F12EB80Q30278601-5CCDF5C0-F2BB-4C01-9375-403385767E8EQ30353712-5BA82B7B-A9F1-40EE-A1BC-D1D0A49BBA48Q30357603-18869F86-03A8-423E-BA0A-FB65E6A32FBFQ30361306-8917A2B3-400A-4566-8AD3-929DF92A20DCQ30371815-AD0AC102-61E0-4A08-BE9A-50631CA2DCA1Q30379566-E7121AC0-C754-4FC1-AF26-8DD47971E808Q30406849-B7C36F98-6F1A-4033-AABC-B1121422CA25Q30411023-3E418CEB-63F8-4E73-AD0F-55A6739EF856Q30426029-31B6F28E-1B59-42AE-BB82-34006E96CC36Q30438479-83DAB452-E012-4B8D-AC6B-54A486D7D0C3Q30443648-E2D5A365-7D80-4B23-95C9-D91B1AB0A4A6Q30449479-21FD94DF-C929-40D5-B8CC-B2289CA7BA8FQ30451364-37485EB9-32DD-4B99-890C-D1189494ED04Q30451729-4F4ECD80-8080-457C-B6CB-1D199675F652Q30451753-D393F746-2AEF-4B45-AA5E-DB6E161EA734Q30464047-B718B90A-D463-4DC2-92BE-CE1D5ECB3F86Q30870696-B45B15D6-3418-4D02-BE84-66C21114A1B5Q31152522-1981890B-064D-4F5B-9A1B-686C0B644C6EQ33324384-024464C7-10CF-477C-A7F0-CEA7DAD5CF9EQ33393454-440788BD-968C-4733-BB0C-633FC314E537Q33979856-87726786-514A-44BC-8028-10529DD093F8Q34067095-A62AAAF6-1692-43B5-BC3E-FD575A616F03Q34099223-91099B7D-C9F2-4CA1-A5E5-28B97EAA608AQ34276217-7BCC3E28-C8BD-4CDE-8AB6-4A5C6F46479EQ34331417-9D4E79FA-8324-424B-8A08-78AFA4D2A986Q34403927-13C8CDDE-E480-40D2-B395-01FA0AC824C9
P2860
Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity.
description
1958 nî lūn-bûn
@nan
1958 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1958 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1958年の論文
@ja
1958年論文
@yue
1958年論文
@zh-hant
1958年論文
@zh-hk
1958年論文
@zh-mo
1958年論文
@zh-tw
1958年论文
@wuu
name
Transmission of the common col ...... mon cold as a clinical entity.
@ast
Transmission of the common col ...... mon cold as a clinical entity.
@en
Transmission of the common col ...... mon cold as a clinical entity.
@nl
type
label
Transmission of the common col ...... mon cold as a clinical entity.
@ast
Transmission of the common col ...... mon cold as a clinical entity.
@en
Transmission of the common col ...... mon cold as a clinical entity.
@nl
prefLabel
Transmission of the common col ...... mon cold as a clinical entity.
@ast
Transmission of the common col ...... mon cold as a clinical entity.
@en
Transmission of the common col ...... mon cold as a clinical entity.
@nl
P2093
P1476
Transmission of the common col ...... mon cold as a clinical entity.
@en
P2093
DOWLING HF
JACKSON GG
SPIESMAN IG
P304
P356
10.1001/ARCHINTE.1958.00260140099015
P407
P577
1958-02-01T00:00:00Z